I. Definition & Epidemiology: Beyond “Juvenile-Onset” Diabetes Type 1 diabetes mellitus (T1D) is an immune-mediated disorder characterized by progressive, T cell–mediated destruction of pancreatic β-cells leading to absolute or near-absolute…
Prepared for Clinicians 1. Definition & Anatomic Classification A urinary tract infection (UTI) is defined as the presence of pathogenic microorganisms in the urinary tract accompanied by host inflammatory response.…
Prepared for the Practicing Clinician – Evidence-Based Overview with Emphasis on Clinical Decision-Making 1. Disease Classification and Genetic Basis Polycystic kidney disease (PKD) encompasses two major hereditary forms—autosomal dominant PKD…
Prepared with reference to 2023–2024 guidelines from the American College of Rheumatology (ACR), European Alliance of Associations for Rheumatology (EULAR), Kidney Disease: Improving Global Outcomes (KDIGO), and peer-reviewed literature (e.g.,…
Prepared for the Practicing Cardiologist or Internal Medicine Physician 1. Definition & Epidemiology Congenital heart disease (CHD) refers to structural abnormalities of the heart or great vessels present at birth,…
The MRCP PACES (Practical Assessment of Clinical Examination Skills) exam remains one of the most daunting—but also deeply rewarding—milestones for doctors aiming to become members of the Royal College of…
Updated with Current Evidence-Based Guidelines (2023–2024) Epidemiology and Pathobiological Context Small cell lung carcinoma (SCLC) accounts for approximately 13–15% of all primary lung cancers, with an incidence declining modestly over…
Epoetin alfa is a recombinant human erythropoietin (rhEPO) that stimulates erythropoiesis. It is used in the management of anemia associated with chronic kidney disease (CKD), chemotherapy, zidovudine therapy in HIV,…
Endless studies When I was 3 years old I started studying in pre-school. Now I am a medical doctor with 10 years of experience. I am still studying every day…
MRCP - overview Membership of the Royal Colleges of Physicians of the UK is a gold standard degree in clinical medicine. A doctor with this medical degree can show a…
Apremilast is an orally administered small molecule approved for the treatment of immune-mediated inflammatory conditions. It is classified as a selective phosphodiesterase 4 (PDE4) inhibitor, with anti-inflammatory properties beneficial in…
Nivolumab is a fully human IgG4 monoclonal antibody that targets the programmed death-1 (PD-1) receptor. By modulating immune checkpoints, nivolumab enhances the body’s antitumor immune response and has transformed the…
Cabozantinib is an oral tyrosine kinase inhibitor (TKI) used in the treatment of several advanced and metastatic cancers. It inhibits multiple pathways involved in tumor growth, angiogenesis, and metastasis, making…
Keytruda® (generic: pembrolizumab) is a humanized monoclonal antibody that works as an immune checkpoint inhibitor, targeting PD-1 (programmed death-1) to restore anti-tumor immune responses. First approved by the FDA in…
1. Introduction & Mechanism of Action Ipilimumab is a humanized IgG4 monoclonal antibody that selectively binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), an inhibitory receptor expressed on activated T cells…
